{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:06:30Z","timestamp":1788811590644,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Russian Scientific Fund","award":["14-15-00034"],"award-info":[{"award-number":["14-15-00034"]}]},{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"crossref","award":["0245-0305"],"award-info":[{"award-number":["0245-0305"]}],"id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.virol.2018.03.013","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T09:07:39Z","timestamp":1521709659000},"page":"313-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin"],"prefix":"10.1016","volume":"518","author":[{"given":"Irina","family":"Isakova-Sivak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8321-778X","authenticated-orcid":false,"given":"Daniil","family":"Korenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Smolonogina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Kotomina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Donina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Matyushenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Mezhenskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Rudenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2018.03.013_bib1","unstructured":"Anon, 2010. Manual for laboratory animals and alternative models in biomedical research [Russian]. Moscow, Russia, Profile-2S."},{"issue":"6","key":"10.1016\/j.virol.2018.03.013_bib2","first-page":"446","article-title":"Analysis of antigenic and biological properties of influenza B virus strains, isolated in Leningrad in 1955\u20131967","volume":"15","author":"Aleksandrova","year":"1971","journal-title":"Acta Virol."},{"issue":"26","key":"10.1016\/j.virol.2018.03.013_bib3","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1016\/j.vaccine.2016.03.085","article-title":"Universal influenza vaccines: shifting to better vaccines","volume":"34","author":"Berlanda Scorza","year":"2016","journal-title":"Vaccine"},{"issue":"6044","key":"10.1016\/j.virol.2018.03.013_bib4","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.virol.2018.03.013_bib5","first-page":"40","article-title":"[A preclinical trial of the reassortant influenza virus vaccine strain A\/17\/quail\/Hong Kong\/97\/84 (H9N2)]","volume":"60","author":"Desheva","year":"2015","journal-title":"Vopr. Virusol."},{"issue":"36","key":"10.1016\/j.virol.2018.03.013_bib6","doi-asserted-by":"crossref","first-page":"13133","DOI":"10.1073\/pnas.1414070111","article-title":"Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans","volume":"111","author":"Ellebedy","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.virol.2018.03.013_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00286-17","article-title":"Chimeric hemagglutinin constructs induce broad protection against influenza B virus challenge in the mouse Model","volume":"91","author":"Ermler","year":"2017","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virol.2018.03.013_bib8","doi-asserted-by":"crossref","first-page":"e79194","DOI":"10.1371\/journal.pone.0079194","article-title":"Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies","volume":"8","author":"Goff","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.virol.2018.03.013_bib9","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/infdis\/jir596","article-title":"Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets","volume":"204","author":"Gustin","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.virol.2018.03.013_bib10","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.00137-12","article-title":"Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes","volume":"86","author":"Hai","year":"2012","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virol.2018.03.013_bib11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.vaccine.2017.01.018","article-title":"\"Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015","volume":"35","author":"Hampson","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.virol.2018.03.013_bib12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s10393-017-1244-y","article-title":"Epidemiological risk factors for animal influenza A viruses overcoming species barriers","volume":"14","author":"Harris","year":"2017","journal-title":"Ecohealth"},{"key":"10.1016\/j.virol.2018.03.013_bib13","doi-asserted-by":"crossref","unstructured":"Hughes, B., Hayden, F., Perikov, Y., Hombach, J., Tam, J.S., 2012. \"Report. In: Proceedings of the 5th meeting on influenza vaccines that induce broad spectrum and long-lasting immune responses, World Health Organization, Geneva, 16-17 November 2011.\" Vaccine 30(47): pp. 6612\u20136622.","DOI":"10.1016\/j.vaccine.2012.08.073"},{"key":"10.1016\/j.virol.2018.03.013_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2017.09.008","article-title":"A highly pathogenic Avian H7N9 influenza virus isolated from A human is lethal in some ferrets infected via respiratory droplets","author":"Imai","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"6254","key":"10.1016\/j.virol.2018.03.013_bib15","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.virol.2018.03.013_bib16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/CVI.00819-13","article-title":"Characterization of reverse genetics-derived cold-adapted master donor virus A\/Leningrad\/134\/17\/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model","volume":"21","author":"Isakova-Sivak","year":"2014","journal-title":"Clin. Vaccin. Immunol."},{"issue":"2","key":"10.1016\/j.virol.2018.03.013_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.virol.2011.01.004","article-title":"Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: a\/leningrad\/134\/17\/57 (H2N2)","volume":"412","author":"Isakova-Sivak","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.03.013_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.virol.2016.10.027","article-title":"Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model","volume":"500","author":"Isakova-Sivak","year":"2017","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.virol.2018.03.013_bib19","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1586\/14760584.2015.1075883","article-title":"Safety, immunogenicity and infectivity of new live attenuated influenza vaccines","volume":"14","author":"Isakova-Sivak","year":"2015","journal-title":"Exp. Rev. Vaccin."},{"issue":"5","key":"10.1016\/j.virol.2018.03.013_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01463-17","article-title":"Influenza virus hemagglutinin stalk-specific antibodies in human serum are a surrogate marker for in vivo protection in a serum transfer mouse challenge model","volume":"8","author":"Jacobsen","year":"2017","journal-title":"MBio"},{"issue":"Pt 4","key":"10.1016\/j.virol.2018.03.013_bib21","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1099\/vir.0.017996-0","article-title":"PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B\/USSR\/60\/69 influenza master donor virus","volume":"91","author":"Kiseleva","year":"2010","journal-title":"J. Gen. Virol."},{"issue":"5","key":"10.1016\/j.virol.2018.03.013_bib22","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/biot.201400393","article-title":"\"Emerging influenza viruses and the prospect of a universal influenza virus vaccine","volume":"10","author":"Krammer","year":"2015","journal-title":"Biotechnol. J."},{"issue":"6","key":"10.1016\/j.virol.2018.03.013_bib23","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1128\/JVI.03004-13","article-title":"Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets","volume":"88","author":"Krammer","year":"2014","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2018.03.013_bib24","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1128\/JVI.03183-13","article-title":"H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge","volume":"88","author":"Krammer","year":"2014","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virol.2018.03.013_bib25","doi-asserted-by":"crossref","first-page":"e43603","DOI":"10.1371\/journal.pone.0043603","article-title":"A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates","volume":"7","author":"Krammer","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.virol.2018.03.013_bib26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr. Opin. Virol."},{"issue":"12","key":"10.1016\/j.virol.2018.03.013_bib27","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J. Virol."},{"issue":"19","key":"10.1016\/j.virol.2018.03.013_bib28","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.1128\/JVI.01336-12","article-title":"Hemagglutinin stalk-reactive antibodies are boosted following sequential infection with seasonal and pandemic H1N1 influenza virus in mice","volume":"86","author":"Krammer","year":"2012","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2018.03.013_bib29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/infdis\/jiw608","article-title":"Induction of broadly cross-reactive stalk-specific antibody responses to Influenza Group 1 and Group 2 hemagglutinins by natural H7N9 virus infection in humans","volume":"215","author":"Liu","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virol.2018.03.013_bib30","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/146.6.780","article-title":"Evaluation of a cold-recombinant influenza virus vaccine in ferrets","volume":"146","author":"Maassab","year":"1982","journal-title":"J. Infect. Dis."},{"issue":"19","key":"10.1016\/j.virol.2018.03.013_bib31","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses","volume":"87","author":"Margine","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.013_bib32","first-page":"e51112","article-title":"Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system","volume":"81","author":"Margine","year":"2013","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.virol.2018.03.013_bib33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/infdis\/jis652","article-title":"1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans","volume":"207","author":"Miller","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2018.03.013_bib34","first-page":"1","article-title":"A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice","author":"Nachbagauer","year":"2016","journal-title":"NPJ Vaccin."},{"issue":"4","key":"10.1016\/j.virol.2018.03.013_bib35","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmi.2017.02.009","article-title":"Universal influenza virus vaccines and therapeutic antibodies","volume":"23","author":"Nachbagauer","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"issue":"26","key":"10.1016\/j.virol.2018.03.013_bib36","first-page":"1","article-title":"A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies","volume":"2","author":"Nachbagauer","year":"2017","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.virol.2018.03.013_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41541-017-0026-4","article-title":"A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies","volume":"2","author":"Nachbagauer","year":"2017","journal-title":"NPJ Vaccin."},{"issue":"6","key":"10.1016\/j.virol.2018.03.013_bib38","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.02481-15","article-title":"Hemagglutinin stalk immunity reduces influenza virus replication and transmission in ferrets","volume":"90","author":"Nachbagauer","year":"2015","journal-title":"J. Virol."},{"issue":"22","key":"10.1016\/j.virol.2018.03.013_bib39","doi-asserted-by":"crossref","first-page":"13260","DOI":"10.1128\/JVI.02133-14","article-title":"Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans","volume":"88","author":"Nachbagauer","year":"2014","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2018.03.013_bib40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.immuni.2017.09.007","article-title":"The pathway to a universal influenza vaccine","volume":"47","author":"Paules","year":"2017","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.virol.2018.03.013_bib41","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/cid\/cix608","article-title":"The household influenza vaccine effectiveness study: lack of antibody response and protection following receipt of 2014\u20132015 influenza vaccine","volume":"65","author":"Petrie","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.virol.2018.03.013_bib42","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1073\/pnas.1200039109","article-title":"Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses","volume":"109","author":"Pica","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2018.03.013_bib43","first-page":"51","article-title":"The avian influenza H9N2 at avian-human interface: a possible risk for the future pandemics","volume":"21","author":"RahimiRad","year":"2016","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.virol.2018.03.013_bib44","doi-asserted-by":"crossref","first-page":"9359276","DOI":"10.1155\/2017\/9359276","article-title":"Immunogenicity and cross protection in mice afforded by pandemic H1N1 live attenuated influenza vaccine containing wild-type nucleoprotein","volume":"2017","author":"Rekstin","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.virol.2018.03.013_bib45","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/femsre\/fuv039","article-title":"Influenza A virus transmission via respiratory aerosols or droplets as it relates to pandemic potential","volume":"40","author":"Richard","year":"2016","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.virol.2018.03.013_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2016.08.018","article-title":"Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: process challenges and success stories","author":"Rudenko","year":"2016","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.virol.2018.03.013_bib47","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1128\/JVI.02598-15","article-title":"Vaccination with vesicular stomatitis virus-vectored Chimeric hemagglutinins protects mice against divergent influenza virus challenge strains","volume":"90","author":"Ryder","year":"2015","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virol.2018.03.013_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00502-17","article-title":"Vaccination with a recombinant H7 hemagglutinin-based influenza virus vaccine induces broadly reactive antibodies in humans","volume":"2","author":"Stadlbauer","year":"2017","journal-title":"mSphere"},{"issue":"11","key":"10.1016\/j.virol.2018.03.013_bib49","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1080\/14760584.2017.1379396","article-title":"Vaccine approaches conferring cross-protection against influenza viruses","volume":"16","author":"Vemula","year":"2017","journal-title":"Exp. Rev. Vaccin."},{"key":"10.1016\/j.virol.2018.03.013_bib50","article-title":"Potential impact of B lineage mismatch on trivalent influenza vaccine effectiveness during the 2015\u20132016 influenza season among nursery school children in Suzhou, China","volume":"0","author":"Wang","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"issue":"1","key":"10.1016\/j.virol.2018.03.013_bib51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jmv.2017","article-title":"Immunogenic and isotype-specific responses to Russian and US cold-adapted influenza a vaccine donor strains A\/Leningrad\/134\/17\/57, A\/Leningrad\/134\/47\/57, and A\/Ann Arbor\/6\/60 (H2N2) in mice","volume":"65","author":"Wareing","year":"2001","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2018.03.013_bib52","unstructured":"WHO, 2016. \"Influenza (Seasonal). Fact sheet. Available from: \u3008http:\/\/www.who.int\/mediacentre\/factsheets\/fs211\/en\/\u3009\"."},{"issue":"29","key":"10.1016\/j.virol.2018.03.013_bib53","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1016\/j.vaccine.2015.05.038","article-title":"Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses","volume":"33","author":"Wohlbold","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.virol.2018.03.013_bib54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/laban0511-155","article-title":"Retro-orbital injections in mice","volume":"40","author":"Yardeni","year":"2011","journal-title":"Lab. Anim. (NY)"},{"issue":"9","key":"10.1016\/j.virol.2018.03.013_bib55","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.virol.2018.03.013_bib56","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.chom.2015.02.006","article-title":"A human-infecting H10N8 influenza virus retains a strong preference for avian-type receptors","volume":"17","author":"Zhang","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2018.03.013_bib57","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1712377114","article-title":"Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains","author":"Zost","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682218300941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682218300941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:49:08Z","timestamp":1758588548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682218300941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":57,"alternative-id":["S0042682218300941"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2018.03.013","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2018.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}